statistiche ricercatore

Continente	#
NA - Nord America	410
EU - Europa	270
AS - Asia	259
SA - Sud America	51
Continente sconosciuto - Info sul continente non disponibili	39
AF - Africa	13
OC - Oceania	5
Totale	1.047

Nazione	#
US - Stati Uniti d'America	385
IT - Italia	132
SG - Singapore	97
CN - Cina	51
DE - Germania	42
BR - Brasile	41
HK - Hong Kong	37
RU - Federazione Russa	23
VN - Vietnam	22
BD - Bangladesh	14
FR - Francia	14
GB - Regno Unito	14
FI - Finlandia	13
CA - Canada	10
CI - Costa d'Avorio	9
ID - Indonesia	8
IN - India	7
JP - Giappone	6
NL - Olanda	6
HN - Honduras	5
AU - Australia	4
ES - Italia	4
PL - Polonia	4
TR - Turchia	4
AT - Austria	3
CO - Colombia	3
CZ - Repubblica Ceca	3
IL - Israele	3
PH - Filippine	3
AR - Argentina	2
CW - ???statistics.table.value.countryCode.CW???	2
EC - Ecuador	2
ET - Etiopia	2
MX - Messico	2
MY - Malesia	2
NI - Nicaragua	2
SE - Svezia	2
SV - El Salvador	2
AL - Albania	1
BE - Belgio	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
DK - Danimarca	1
GR - Grecia	1
GT - Guatemala	1
GY - Guiana	1
IE - Irlanda	1
IQ - Iraq	1
IR - Iran	1
LK - Sri Lanka	1
LV - Lettonia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PY - Paraguay	1
RS - Serbia	1
SA - Arabia Saudita	1
SC - Seychelles	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
Totale	1.010

Nome	#
DECONSTRUCTING ONC201 TO DESIGN NEW MITOCHONDRIAL ClpP ACTIVATORS FOR PEDIATRIC H3K27-ALTERED DIFFUSE MIDLINE GLIOMA	139
The Role of Cannabinoid Receptors Subtype 2 inCancer A Promising Therapeutical Target	134
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)	127
DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation	123
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance	97
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs	95
Controlling the Binding Efficiency of Surface Confined Antibodies through the Design of Mixed Self-Assembled Monolayers	95
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal	94
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2Agonists with Neuroprotective Effects	86
From 18F-MC225 to Conformationally Free Derivatives	25
Virtual screening-guided repurposing of fluorescent probes to detect EGFR expression in renal cells	20
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids	12
Totale	1.047

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	2	0	0	0	0	0	0	0	0	0	0	2	0
2023/2024	18	0	0	0	2	0	2	0	0	1	5	1	7
2024/2025	160	5	0	4	5	10	16	29	17	11	10	11	42
2025/2026	659	56	24	77	90	70	47	73	11	61	62	25	63
2026/2027	208	37	27	53	91	0	0	0	0	0	0	0	0
Totale													1.047